Serum Free Light Chain Analysis
AR Bradwell.
Updated information on Freelite assays
The latest edition of this popular book includes new clinical data, published in the last 12 months, on the utility of serum free light chains for improved diagnosis, monitoring, and measurement of treatment efficacy in Multiple Myeloma and AL amyloidosis.
The new clinical data comes from both specialist myeloma groups and clinical laboratories now using the serum free light chain assay routinely to diagnose and monitor patients with Light Chain Multiple Myeloma, Nonsecretory Multiple Myeloma, AL amyloidosis and other myelomas.
This soft-back version includes:
- new guidelines on the diagnosis and monitoring of myeloma
- a new section discussing the use of serum free light chains for risk stratification of MGUS (Monoclonal Gammopathy of Undetermined Significance)
- an additional chapter explaining the advantages of using serum samples instead of urine for kappa and lambda free light chain measurements
The book is available to order US $75.
Click here to find a local supplier near you.
